A detailed history of Tactive Advisors, LLC transactions in Shockwave Medical, Inc. stock. As of the latest transaction made, Tactive Advisors, LLC holds 800 shares of SWAV stock, worth $0. This represents 0.14% of its overall portfolio holdings.

Number of Shares
800
Holding current value
$0
% of portfolio
0.14%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Jun 04, 2024

BUY
$191.17 - $325.63 $152,936 - $260,504
800 New
800 $261 Million
Q3 2023

Feb 02, 2024

SELL
$194.33 - $283.97 $163,237 - $238,534
-840 Closed
0 $0
Q2 2023

Feb 02, 2024

BUY
$223.05 - $302.68 $187,362 - $254,251
840 New
840 $239,000

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Tactive Advisors, LLC Portfolio

Follow Tactive Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tactive Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tactive Advisors, LLC with notifications on news.